États-Unis · Plateformes & données · TipRanks

ADARx Pharmaceuticals Reports Third-Quarter 2026 Results and Updates

Publié par TipRanks · États-Unis il y a 9 h

Résumé détaillé

On November 12, 2026, ADARx updated its corporate presentation and reported third-quarter 2026 financial results and business updates. In August 2026, the FDA granted Fast Track d…

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

ADARx Pharmaceuticals Reports Third-Quarter 2026 Results and Updates

Résumé détaillé

À lire aussi

Investors Purchase High Volume of Put Options on Boeing (NYSE:BA)

Opening trading-card packs has become a $2 billion market

Crown Crafts GAAP EPS of $0.12, revenue of $19.03M

e.l.f. Beauty vs. lululemon athletica: Which Consumer Goods Stock Is a Better Buy for 2027?

Earnings call transcript: LifeMD Q3 2026 revenue miss sends shares lower

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

ADARx Pharmaceuticals Reports Third-Quarter 2026 Results and Updates

Résumé détaillé

Partager

À lire aussi

Investors Purchase High Volume of Put Options on Boeing (NYSE:BA)

Opening trading-card packs has become a $2 billion market

Crown Crafts GAAP EPS of $0.12, revenue of $19.03M

e.l.f. Beauty vs. lululemon athletica: Which Consumer Goods Stock Is a Better Buy for 2027?

Earnings call transcript: LifeMD Q3 2026 revenue miss sends shares lower

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates